Lupien, Mathieu

Biography

Dr. Mathieu Lupien has been a scientist at the Princess Margaret Cancer Centre since 2012 and is an assistant professor in the Department of Medical Biophysics at the University of Toronto. He also has a cross-appointment with the Ontario Institute for Cancer Research (OICR). He earned his Ph.D. at McGill University (Montreal, Canada) in 2005, followed by post-doctoral training in medical oncology at the Dana-Farber Cancer Institute, Harvard Medical School (Boston, MA) as an Era of Hope fellow. Dr. Lupien completed his post-doctoral training in 2008 and was recruited as a faculty member at the Dartmouth Medical School (Hanover, NH) in 2009, where he became Director of the Quantitative Epigenomics Laboratory. Dr. Lupien has co-authored numerous peer-reviewed publications, including seminal work reported in high-impact journals including Science, Cell, Nature Genetics and The Journal of the National Cancer Institute. Among other honours, Dr. Lupien is a recipient of the Young Investigator Award from the OICR, the New Investigator Salary Award from CIHR, The Rising Star in Prostate Cancer Research award from PCC/Movember and the Till and McCulloch Discovery of the Year award. Dr. Mathieu Lupien has been a scientist at the Princess Margaret Cancer Centre since 2012 and is an assistant professor in the Department of Medical Biophysics at the University of Toronto. He also has a cross-appointment with the Ontario Institute for Cancer Research (OICR). He earned his Ph.D. at McGill University (Montreal, Canada) in 2005, followed by post-doctoral training in medical oncology at the Dana-Farber Cancer Institute, Harvard Medical School (Boston, MA) as an Era of Hope fellow. Dr. Lupien completed his post-doctoral training in 2008 and was recruited as a faculty member at the Dartmouth Medical School (Hanover, NH) in 2009, where he became Director of the Quantitative Epigenomics Laboratory. Dr. Lupien has co-authored numerous peer-reviewed publications, including seminal work reported in high-impact journals including Science, Cell, Nature Genetics and The Journal of the National Cancer Institute. Among other honours, Dr. Lupien is a recipient of the Young Investigator Award from the OICR, the New Investigator Salary Award from CIHR, The Rising Star in Prostate Cancer Research award from PCC/Movember and the Till and McCulloch Discovery of the Year award.

Research Interest

Research in the Lupien lab focuses on the Epigenetics of cancer, with an emphasis on comprehensive data analytics and mid to high-throughput biological assays. The laboratory provides a unique environment where both wet laboratory scientists and computational biologists thrive. Data generation relies on next-generation sequencing based assays and new mid to high-throughput profiling technologies Data analytics relies on existing software and on in-house algorithmic and software development